How weight-loss injections are turning obesity into a wealth issue

Weight-loss injections like Wegovy and Mounjaro are gaining popularity for treating obesity, with celebrities like Serena Williams and Elon Musk endorsing them. Despite some NHS prescriptions, a two-tier system is emerging, benefiting the well-off due to varying eligibility criteria. Concerns about cost and accessibility highlight the potential wealth issue surrounding weight-loss drugs, raising questions about societal health inequalities and medicalizing obesity.